Schnieders Capital Management LLC boosted its stake in Medical Properties Trust, Inc. (NYSE:MPW) by 5.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 192,950 shares of the real estate investment trust’s stock after buying an additional 9,250 shares during the period. Schnieders Capital Management LLC owned 0.05% of Medical Properties Trust worth $2,483,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in MPW. Public Employees Retirement Association of Colorado purchased a new stake in shares of Medical Properties Trust during the second quarter valued at $147,000. RMR Advisors LLC raised its stake in shares of Medical Properties Trust by 5.7% in the second quarter. RMR Advisors LLC now owns 370,320 shares of the real estate investment trust’s stock valued at $4,766,000 after buying an additional 20,000 shares in the last quarter. Cubic Asset Management LLC raised its stake in shares of Medical Properties Trust by 14.1% in the second quarter. Cubic Asset Management LLC now owns 224,325 shares of the real estate investment trust’s stock valued at $2,887,000 after buying an additional 27,635 shares in the last quarter. Paragon Capital Management Ltd raised its stake in shares of Medical Properties Trust by 58.2% in the second quarter. Paragon Capital Management Ltd now owns 20,225 shares of the real estate investment trust’s stock valued at $260,000 after buying an additional 7,443 shares in the last quarter. Finally, Naples Global Advisors LLC raised its stake in shares of Medical Properties Trust by 3.1% in the second quarter. Naples Global Advisors LLC now owns 25,605 shares of the real estate investment trust’s stock valued at $330,000 after buying an additional 775 shares in the last quarter. 82.12% of the stock is currently owned by institutional investors.
Medical Properties Trust, Inc. (MPW) traded down 0.79% during midday trading on Friday, reaching $12.51. The company had a trading volume of 2,378,049 shares. The stock has a 50-day moving average price of $12.75 and a 200 day moving average price of $13.03. Medical Properties Trust, Inc. has a 12-month low of $11.54 and a 12-month high of $15.74. The company has a market capitalization of $4.38 billion, a PE ratio of 15.29 and a beta of 0.89.
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 12th. Stockholders of record on Thursday, September 14th will be issued a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.67%. The ex-dividend date of this dividend is Wednesday, September 13th. Medical Properties Trust’s payout ratio is 115.66%.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.com-unik.info/2017/08/19/schnieders-capital-management-llc-buys-9250-shares-of-medical-properties-trust-inc-nysempw-updated-updated.html.
MPW has been the topic of several recent analyst reports. Zacks Investment Research raised Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 price target on the stock in a research note on Wednesday, July 19th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $16.00 price target on shares of Medical Properties Trust in a research note on Monday, July 24th. Jefferies Group LLC reiterated a “buy” rating and issued a $16.00 price objective (up previously from $15.00) on shares of Medical Properties Trust in a research report on Friday, June 9th. Deutsche Bank AG lifted their price objective on Medical Properties Trust from $13.50 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, July 4th. Finally, ValuEngine upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $14.20.
In other news, CFO R Steven Hamner sold 85,000 shares of the stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total transaction of $1,135,600.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.00% of the company’s stock.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
What are top analysts saying about Medical Properties Trust Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medical Properties Trust Inc. and related companies.